Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

Ischemia Detection During Development of Acute Compartment Syndrome

Study ID: NCT06079255
Start Date: 2025-10-15
End Date: 2027-10-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

IscAlert sensor(s) in patient with risk of acute compartment syndrome

Sponsor

Oslo University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Care in Multiple Sclerosis (MS)

Study ID: NCT07011914
Start Date: 2025-09-01
End Date: 2029-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

386

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Ronnie Gardiner Method in Individuals With Stroke in Late Phase of Recovery

Study ID: NCT06979050
Start Date: 2025-07-21
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

The Ronnie Gardiner Method

Sponsor

Gothenburg University

Source: clinicaltrials.gov

Share:
Add to list

Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study ID: NCT05731050
Start Date: 2026-06
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

Nm8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Study ID: NCT07032714
Start Date: 2025-12-16
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

25

Intervention / Treatment

Talkqueamab

Mezigdomide

Dexamethasone

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

Study ID: NCT07056894
Start Date: 2025-11-01
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Action-Based Cognitive Remediation

Sponsor

Nova Scotia Health Authority

Source: clinicaltrials.gov

Share:
Add to list

Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia

Study ID: NCT06752694
Start Date: 2025-08-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Bone Marrow Transplantation

Computed Tomography

Cyclosporine

Fludarabine

Granulocyte Colony-Stimulating Factor

Mycophenolate Mofetil

Peripheral Blood Stem Cell Transplantation

Rheops

Sirolimus

Total-Body Irradiation

Multigated Acquisition Scan

Echocardiography

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Study ID: NCT07060989
Start Date: 2025-08
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

220

Intervention / Treatment

Nts071

Sponsor

Nutshell Therapeutics (Shanghai) Co., LTD.

Source: clinicaltrials.gov

Share:
Add to list

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Study ID: NCT06600880
Start Date: 2026-08
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Neuronavigation-guided single-element focused ultrasound transducer

Lumason

Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents

Positron Emission Tomography (PET)

Amyvid

MK-6240

Two

Blood draw

Ur5e

Urine test

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Study ID: NCT06484062
Start Date: 2025-09-16
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

54

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Cirtuvivint

Decitabine and Cedazuridine

Echocardiography Test

Multigated Acquisition Scan

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list